> top > docs > PubMed:20034406 > annotations

PubMed:20034406 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-119 Sentence denotes Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus.
T2 120-131 Sentence denotes BACKGROUND:
T3 132-209 Sentence denotes Neuroinflammation occurs after seizures and is implicated in epileptogenesis.
T4 210-375 Sentence denotes CCR2 is a chemokine receptor for CCL2 and their interaction mediates monocyte infiltration in the neuroinflammatory cascade triggered in different brain pathologies.
T5 376-495 Sentence denotes In this work CCR2 and CCL2 expression were examined following status epilepticus (SE) induced by pilocarpine injection.
T6 496-545 Sentence denotes METHODS: SE was induced by pilocarpine injection.
T7 546-608 Sentence denotes Control rats were injected with saline instead of pilocarpine.
T8 609-717 Sentence denotes Five days after SE, CCR2 staining in neurons and glial cells was examined using imunohistochemical analyses.
T9 718-810 Sentence denotes The number of CCR2 positive cells was determined using stereology probes in the hippocampus.
T10 811-878 Sentence denotes CCL2 expression in the hippocampus was examined by molecular assay.
T11 879-887 Sentence denotes RESULTS:
T12 888-944 Sentence denotes Increased CCR2 was observed in the hippocampus after SE.
T13 945-1017 Sentence denotes Seizures also resulted in alterations to the cell types expressing CCR2.
T14 1018-1093 Sentence denotes Increased numbers of neurons that expressed CCR2 was observed following SE.
T15 1094-1174 Sentence denotes Microglial cells were more closely apposed to the CCR2-labeled cells in SE rats.
T16 1175-1317 Sentence denotes In addition, rats that experienced SE exhibited CCR2-labeling in populations of hypertrophied astrocytes, especially in CA1 and dentate gyrus.
T17 1318-1376 Sentence denotes These CCR2+ astroctytes were not observed in control rats.
T18 1377-1468 Sentence denotes Examination of CCL2 expression showed that it was elevated in the hippocampus following SE.
T19 1469-1480 Sentence denotes CONCLUSION:
T20 1481-1579 Sentence denotes The data show that CCR2 and CCL2 are up-regulated in the hippocampus after pilocarpine-induced SE.
T21 1580-1666 Sentence denotes Seizures also result in changes to CCR2 receptor expression in neurons and astrocytes.
T22 1667-1790 Sentence denotes These changes might be involved in detrimental neuroplasticity and neuroinflammatory changes that occur following seizures.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 58-69 OrganismTaxon denotes hippocampus NCBItxid:72046
T2 554-558 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T5 798-809 OrganismTaxon denotes hippocampus NCBItxid:72046
T6 834-845 OrganismTaxon denotes hippocampus NCBItxid:72046
T7 923-934 OrganismTaxon denotes hippocampus NCBItxid:72046
T8 1169-1173 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T11 1188-1192 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T14 1371-1375 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T17 1443-1454 OrganismTaxon denotes hippocampus NCBItxid:72046
T18 1538-1549 OrganismTaxon denotes hippocampus NCBItxid:72046

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
6894 10-14 GeneOrGeneProduct denotes CCL2 NCBIGene:24770
6895 32-36 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6896 80-91 ChemicalEntity denotes pilocarpine MESH:D010862
6897 100-118 DiseaseOrPhenotypicFeature denotes status epilepticus MESH:D013226
6898 132-149 DiseaseOrPhenotypicFeature denotes Neuroinflammation MESH:D007249
6899 163-171 DiseaseOrPhenotypicFeature denotes seizures MESH:D012640
6900 210-214 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6901 220-238 GeneOrGeneProduct denotes chemokine receptor NCBIGene:60463
6902 243-247 GeneOrGeneProduct denotes CCL2 NCBIGene:24770
6903 308-325 DiseaseOrPhenotypicFeature denotes neuroinflammatory MESH:D007249
6904 389-393 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6905 398-402 GeneOrGeneProduct denotes CCL2 NCBIGene:24770
6906 438-456 DiseaseOrPhenotypicFeature denotes status epilepticus MESH:D013226
6907 458-460 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6908 473-484 ChemicalEntity denotes pilocarpine MESH:D010862
6909 505-507 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6910 523-534 ChemicalEntity denotes pilocarpine MESH:D010862
6911 554-558 OrganismTaxon denotes rats NCBITaxon:10116
6912 596-607 ChemicalEntity denotes pilocarpine MESH:D010862
6913 625-627 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6914 629-633 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6915 732-736 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6916 811-815 GeneOrGeneProduct denotes CCL2 NCBIGene:24770
6917 898-902 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6918 941-943 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6919 945-953 DiseaseOrPhenotypicFeature denotes Seizures MESH:D012640
6920 1012-1016 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6921 1062-1066 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6922 1090-1092 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6923 1144-1148 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6924 1166-1168 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6925 1169-1173 OrganismTaxon denotes rats NCBITaxon:10116
6926 1188-1192 OrganismTaxon denotes rats NCBITaxon:10116
6927 1210-1212 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6928 1223-1227 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6929 1324-1328 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6930 1371-1375 OrganismTaxon denotes rats NCBITaxon:10116
6931 1392-1396 GeneOrGeneProduct denotes CCL2 NCBIGene:24770
6932 1465-1467 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6933 1500-1504 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6934 1509-1513 GeneOrGeneProduct denotes CCL2 NCBIGene:24770
6935 1556-1567 ChemicalEntity denotes pilocarpine MESH:D010862
6936 1576-1578 DiseaseOrPhenotypicFeature denotes SE MESH:D013226
6937 1580-1588 DiseaseOrPhenotypicFeature denotes Seizures MESH:D012640
6938 1615-1619 GeneOrGeneProduct denotes CCR2 NCBIGene:60463
6939 1734-1751 DiseaseOrPhenotypicFeature denotes neuroinflammatory MESH:D007249
6940 1781-1789 DiseaseOrPhenotypicFeature denotes seizures MESH:D012640

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 100-118 DiseaseOrPhenotypicFeature denotes status epilepticus 0002125
T2 438-456 DiseaseOrPhenotypicFeature denotes status epilepticus 0002125
T3 646-653 DiseaseOrPhenotypicFeature denotes neurons 0004466
T4 1039-1046 DiseaseOrPhenotypicFeature denotes neurons 0004466
T5 1643-1650 DiseaseOrPhenotypicFeature denotes neurons 0004466

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 554-558 OrganismTaxon denotes rats
T2 1169-1173 OrganismTaxon denotes rats
T3 1188-1192 OrganismTaxon denotes rats
T4 1371-1375 OrganismTaxon denotes rats

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 0-9 GeneOrGeneProduct denotes Chemokine
T2 10-14 GeneOrGeneProduct denotes CCL2
T3 23-31 GeneOrGeneProduct denotes receptor
T4 32-36 GeneOrGeneProduct denotes CCR2
T5 163-171 GeneOrGeneProduct denotes seizures
T6 210-214 GeneOrGeneProduct denotes CCR2
T7 220-238 GeneOrGeneProduct denotes chemokine receptor
T8 243-247 GeneOrGeneProduct denotes CCL2
T9 357-362 GeneOrGeneProduct denotes brain
T10 389-393 GeneOrGeneProduct denotes CCR2
T11 398-402 GeneOrGeneProduct denotes CCL2
T12 629-633 GeneOrGeneProduct denotes CCR2
T13 732-736 GeneOrGeneProduct denotes CCR2
T14 811-815 GeneOrGeneProduct denotes CCL2
T15 898-902 GeneOrGeneProduct denotes CCR2
T16 945-953 GeneOrGeneProduct denotes Seizures
T17 990-994 GeneOrGeneProduct denotes cell
T18 1012-1016 GeneOrGeneProduct denotes CCR2
T19 1062-1066 GeneOrGeneProduct denotes CCR2
T20 1144-1148 GeneOrGeneProduct denotes CCR2
T21 1223-1227 GeneOrGeneProduct denotes CCR2
T22 1324-1328 GeneOrGeneProduct denotes CCR2
T23 1392-1396 GeneOrGeneProduct denotes CCL2
T24 1500-1504 GeneOrGeneProduct denotes CCR2
T25 1509-1513 GeneOrGeneProduct denotes CCL2
T26 1580-1588 GeneOrGeneProduct denotes Seizures
T27 1615-1619 GeneOrGeneProduct denotes CCR2
T28 1620-1628 GeneOrGeneProduct denotes receptor
T29 1781-1789 GeneOrGeneProduct denotes seizures

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 0-9 GeneOrGeneProduct denotes Chemokine
T2 10-14 GeneOrGeneProduct denotes CCL2
T3 23-31 GeneOrGeneProduct denotes receptor
T4 32-36 GeneOrGeneProduct denotes CCR2
T5 92-99 GeneOrGeneProduct denotes induced
T6 163-171 GeneOrGeneProduct denotes seizures
T7 210-214 GeneOrGeneProduct denotes CCR2
T8 220-238 GeneOrGeneProduct denotes chemokine receptor
T9 243-247 GeneOrGeneProduct denotes CCL2
T10 270-278 GeneOrGeneProduct denotes mediates
T11 279-287 GeneOrGeneProduct denotes monocyte
T12 357-362 GeneOrGeneProduct denotes brain
T13 389-393 GeneOrGeneProduct denotes CCR2
T14 398-402 GeneOrGeneProduct denotes CCL2
T15 462-469 GeneOrGeneProduct denotes induced
T16 496-503 GeneOrGeneProduct denotes METHODS
T17 512-519 GeneOrGeneProduct denotes induced
T18 629-633 GeneOrGeneProduct denotes CCR2
T19 664-669 GeneOrGeneProduct denotes cells
T20 732-736 GeneOrGeneProduct denotes CCR2
T21 746-751 GeneOrGeneProduct denotes cells
T22 756-766 GeneOrGeneProduct denotes determined
T23 811-815 GeneOrGeneProduct denotes CCL2
T24 898-902 GeneOrGeneProduct denotes CCR2
T25 945-953 GeneOrGeneProduct denotes Seizures
T26 990-994 GeneOrGeneProduct denotes cell
T27 1012-1016 GeneOrGeneProduct denotes CCR2
T28 1062-1066 GeneOrGeneProduct denotes CCR2
T29 1105-1110 GeneOrGeneProduct denotes cells
T30 1144-1148 GeneOrGeneProduct denotes CCR2
T31 1157-1162 GeneOrGeneProduct denotes cells
T32 1166-1173 GeneOrGeneProduct denotes SE rats
T33 1223-1227 GeneOrGeneProduct denotes CCR2
T34 1295-1298 GeneOrGeneProduct denotes CA1
T35 1324-1328 GeneOrGeneProduct denotes CCR2
T36 1392-1396 GeneOrGeneProduct denotes CCL2
T37 1500-1504 GeneOrGeneProduct denotes CCR2
T38 1509-1513 GeneOrGeneProduct denotes CCL2
T39 1521-1530 GeneOrGeneProduct denotes regulated
T40 1568-1575 GeneOrGeneProduct denotes induced
T41 1580-1588 GeneOrGeneProduct denotes Seizures
T42 1615-1619 GeneOrGeneProduct denotes CCR2
T43 1620-1628 GeneOrGeneProduct denotes receptor
T44 1781-1789 GeneOrGeneProduct denotes seizures

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 100-118 DiseaseOrPhenotypicFeature denotes status epilepticus D013226
T2 132-149 DiseaseOrPhenotypicFeature denotes Neuroinflammation D000090862
T3 163-171 DiseaseOrPhenotypicFeature denotes seizures D012640
T4 438-456 DiseaseOrPhenotypicFeature denotes status epilepticus D013226
T5 458-460 DiseaseOrPhenotypicFeature denotes SE D013226
T6 505-507 DiseaseOrPhenotypicFeature denotes SE D013226
T7 625-627 DiseaseOrPhenotypicFeature denotes SE D013226
T8 941-943 DiseaseOrPhenotypicFeature denotes SE D013226
T9 945-953 DiseaseOrPhenotypicFeature denotes Seizures D012640
T10 1090-1092 DiseaseOrPhenotypicFeature denotes SE D013226
T11 1166-1168 DiseaseOrPhenotypicFeature denotes SE D013226
T12 1210-1212 DiseaseOrPhenotypicFeature denotes SE D013226
T13 1255-1268 DiseaseOrPhenotypicFeature denotes hypertrophied D006984
T14 1465-1467 DiseaseOrPhenotypicFeature denotes SE D013226
T15 1576-1578 DiseaseOrPhenotypicFeature denotes SE D013226
T16 1580-1588 DiseaseOrPhenotypicFeature denotes Seizures D012640
T17 1781-1789 DiseaseOrPhenotypicFeature denotes seizures D012640

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 0-9 GeneOrGeneProduct denotes Chemokine
T2 10-14 GeneOrGeneProduct denotes CCL2
T3 32-36 GeneOrGeneProduct denotes CCR2
T4 210-214 GeneOrGeneProduct denotes CCR2
T5 220-238 GeneOrGeneProduct denotes chemokine receptor
T6 243-247 GeneOrGeneProduct denotes CCL2
T7 389-393 GeneOrGeneProduct denotes CCR2
T8 398-402 GeneOrGeneProduct denotes CCL2
T9 629-633 GeneOrGeneProduct denotes CCR2
T10 732-736 GeneOrGeneProduct denotes CCR2
T11 811-815 GeneOrGeneProduct denotes CCL2
T12 898-902 GeneOrGeneProduct denotes CCR2
T13 1012-1016 GeneOrGeneProduct denotes CCR2
T14 1062-1066 GeneOrGeneProduct denotes CCR2
T15 1144-1148 GeneOrGeneProduct denotes CCR2
T16 1223-1227 GeneOrGeneProduct denotes CCR2
T17 1324-1328 GeneOrGeneProduct denotes CCR2
T18 1392-1396 GeneOrGeneProduct denotes CCL2
T19 1500-1504 GeneOrGeneProduct denotes CCR2
T20 1509-1513 GeneOrGeneProduct denotes CCL2
T21 1615-1619 GeneOrGeneProduct denotes CCR2

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 100-118 DiseaseOrPhenotypicFeature denotes status epilepticus 0002125
T2 132-149 DiseaseOrPhenotypicFeature denotes Neuroinflammation 0004466
T3 438-456 DiseaseOrPhenotypicFeature denotes status epilepticus 0002125
T4 458-460 DiseaseOrPhenotypicFeature denotes SE 0002125
T5 505-507 DiseaseOrPhenotypicFeature denotes SE 0002125
T6 625-627 DiseaseOrPhenotypicFeature denotes SE 0002125
T7 941-943 DiseaseOrPhenotypicFeature denotes SE 0002125
T8 1090-1092 DiseaseOrPhenotypicFeature denotes SE 0002125
T9 1166-1168 DiseaseOrPhenotypicFeature denotes SE 0002125
T10 1210-1212 DiseaseOrPhenotypicFeature denotes SE 0002125
T11 1465-1467 DiseaseOrPhenotypicFeature denotes SE 0002125
T12 1576-1578 DiseaseOrPhenotypicFeature denotes SE 0002125

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 100-118 DiseaseOrPhenotypicFeature denotes status epilepticus D013226
T2 132-149 DiseaseOrPhenotypicFeature denotes Neuroinflammation D000090862
T3 163-171 DiseaseOrPhenotypicFeature denotes seizures D012640
T4 308-325 DiseaseOrPhenotypicFeature denotes neuroinflammatory DISEASE
T5 438-456 DiseaseOrPhenotypicFeature denotes status epilepticus D013226
T6 458-460 DiseaseOrPhenotypicFeature denotes SE D013226
T7 505-507 DiseaseOrPhenotypicFeature denotes SE D013226
T8 625-627 DiseaseOrPhenotypicFeature denotes SE D013226
T9 941-943 DiseaseOrPhenotypicFeature denotes SE D013226
T10 945-953 DiseaseOrPhenotypicFeature denotes Seizures D012640
T11 1090-1092 DiseaseOrPhenotypicFeature denotes SE D013226
T12 1166-1168 DiseaseOrPhenotypicFeature denotes SE D013226
T13 1210-1212 DiseaseOrPhenotypicFeature denotes SE D013226
T14 1255-1268 DiseaseOrPhenotypicFeature denotes hypertrophied D006984
T15 1465-1467 DiseaseOrPhenotypicFeature denotes SE D013226
T16 1576-1578 DiseaseOrPhenotypicFeature denotes SE D013226
T17 1580-1588 DiseaseOrPhenotypicFeature denotes Seizures D012640
T18 1734-1751 DiseaseOrPhenotypicFeature denotes neuroinflammatory DISEASE
T19 1781-1789 DiseaseOrPhenotypicFeature denotes seizures D012640

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 100-118 DiseaseOrPhenotypicFeature denotes status epilepticus D013226
T2 132-149 DiseaseOrPhenotypicFeature denotes Neuroinflammation D000090862
T3 163-171 DiseaseOrPhenotypicFeature denotes seizures D012640
T4 308-325 DiseaseOrPhenotypicFeature denotes neuroinflammatory DISEASE
T5 438-456 DiseaseOrPhenotypicFeature denotes status epilepticus D013226
T6 458-460 DiseaseOrPhenotypicFeature denotes SE D013226
T7 505-507 DiseaseOrPhenotypicFeature denotes SE D013226
T8 625-627 DiseaseOrPhenotypicFeature denotes SE D013226
T9 941-943 DiseaseOrPhenotypicFeature denotes SE D013226
T10 945-953 DiseaseOrPhenotypicFeature denotes Seizures D012640
T11 1090-1092 DiseaseOrPhenotypicFeature denotes SE D013226
T12 1166-1168 DiseaseOrPhenotypicFeature denotes SE D013226
T13 1210-1212 DiseaseOrPhenotypicFeature denotes SE D013226
T14 1255-1268 DiseaseOrPhenotypicFeature denotes hypertrophied D006984
T15 1465-1467 DiseaseOrPhenotypicFeature denotes SE D013226
T16 1576-1578 DiseaseOrPhenotypicFeature denotes SE D013226
T17 1580-1588 DiseaseOrPhenotypicFeature denotes Seizures D012640
T18 1734-1751 DiseaseOrPhenotypicFeature denotes neuroinflammatory DISEASE
T19 1781-1789 DiseaseOrPhenotypicFeature denotes seizures D012640

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 80-91 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T3 473-484 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T5 523-534 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T7 596-607 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462
T9 1556-1567 ChemicalEntity denotes pilocarpine D010862|http://purl.obolibrary.org/obo/CHEBI_39462

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T9 1556-1567 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T7 596-607 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T5 523-534 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T3 473-484 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T1 80-91 ChemicalEntity denotes pilocarpine http://purl.obolibrary.org/obo/CHEBI_39462|D010862
T21 1615-1619 GeneOrGeneProduct denotes CCR2
T20 1509-1513 GeneOrGeneProduct denotes CCL2
T19 1500-1504 GeneOrGeneProduct denotes CCR2
T18 1392-1396 GeneOrGeneProduct denotes CCL2
T17 1324-1328 GeneOrGeneProduct denotes CCR2
T16 1223-1227 GeneOrGeneProduct denotes CCR2
T15 1144-1148 GeneOrGeneProduct denotes CCR2
T14 1062-1066 GeneOrGeneProduct denotes CCR2
T13 1012-1016 GeneOrGeneProduct denotes CCR2
T12 898-902 GeneOrGeneProduct denotes CCR2
T11 811-815 GeneOrGeneProduct denotes CCL2
T10 732-736 GeneOrGeneProduct denotes CCR2
T22746 629-633 GeneOrGeneProduct denotes CCR2
T8 398-402 GeneOrGeneProduct denotes CCL2
T18667 389-393 GeneOrGeneProduct denotes CCR2
T6 243-247 GeneOrGeneProduct denotes CCL2
T86989 220-238 GeneOrGeneProduct denotes chemokine receptor
T4 210-214 GeneOrGeneProduct denotes CCR2
T49989 32-36 GeneOrGeneProduct denotes CCR2
T2 10-14 GeneOrGeneProduct denotes CCL2
T43977 0-9 GeneOrGeneProduct denotes Chemokine
T4248 1781-1789 DiseaseOrPhenotypicFeature denotes seizures D012640
T24695 1734-1751 DiseaseOrPhenotypicFeature denotes neuroinflammatory DISEASE
T7046 1580-1588 DiseaseOrPhenotypicFeature denotes Seizures D012640
T42481 1576-1578 DiseaseOrPhenotypicFeature denotes SE D013226
T3691 1465-1467 DiseaseOrPhenotypicFeature denotes SE D013226
T96823 1255-1268 DiseaseOrPhenotypicFeature denotes hypertrophied D006984
T1716 1210-1212 DiseaseOrPhenotypicFeature denotes SE D013226
T93290 1166-1168 DiseaseOrPhenotypicFeature denotes SE D013226
T52780 1090-1092 DiseaseOrPhenotypicFeature denotes SE D013226
T44565 945-953 DiseaseOrPhenotypicFeature denotes Seizures D012640
T97965 941-943 DiseaseOrPhenotypicFeature denotes SE D013226
T73614 625-627 DiseaseOrPhenotypicFeature denotes SE D013226
T30429 505-507 DiseaseOrPhenotypicFeature denotes SE D013226
T38441 458-460 DiseaseOrPhenotypicFeature denotes SE D013226
T84880 438-456 DiseaseOrPhenotypicFeature denotes status epilepticus D013226
T84988 308-325 DiseaseOrPhenotypicFeature denotes neuroinflammatory DISEASE
T91227 163-171 DiseaseOrPhenotypicFeature denotes seizures D012640
T20319 132-149 DiseaseOrPhenotypicFeature denotes Neuroinflammation D000090862
T35213 100-118 DiseaseOrPhenotypicFeature denotes status epilepticus D013226
T3455 1371-1375 OrganismTaxon denotes rats
T54855 1188-1192 OrganismTaxon denotes rats
T36747 1169-1173 OrganismTaxon denotes rats
T41990 554-558 OrganismTaxon denotes rats

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 163-171 HP_0001250 denotes seizures
T2 438-456 HP_0002133 denotes status epilepticus